Annual CFI
-$37.99 M
-$15.71 M-70.56%
31 December 2023
Summary:
Terns Pharmaceuticals annual cash flow from investing activities is currently -$37.99 million, with the most recent change of -$15.71 million (-70.56%) on 31 December 2023. During the last 3 years, it has fallen by -$44.68 million (-667.56%). TERN annual CFI is now -667.56% below its all-time high of $6.69 million, reached on 31 December 2020.TERN Cash From Investing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly CFI
$31.75 M
-$10.44 M-24.75%
30 September 2024
Summary:
Terns Pharmaceuticals quarterly cash flow from investing activities is currently $31.75 million, with the most recent change of -$10.44 million (-24.75%) on 30 September 2024. Over the past year, it has increased by +$54.06 million (+242.29%). TERN quarterly CFI is now -32.78% below its all-time high of $47.23 million, reached on 31 December 2023.TERN Quarterly CFI Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM CFI
$129.17 M
+$54.06 M+71.98%
30 September 2024
Summary:
Terns Pharmaceuticals TTM cash flow from investing activities is currently $129.17 million, with the most recent change of +$54.06 million (+71.98%) on 30 September 2024. Over the past year, it has increased by +$228.94 million (+229.47%). TERN TTM CFI is now at all-time high.TERN TTM CFI Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TERN Cash From Investing Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -70.6% | +242.3% | +229.5% |
| 3 y3 years | -667.6% | +614.6% | +214.0% |
| 5 y5 years | -695.4% | - | - |
TERN Cash From Investing High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | -667.6% | +68.3% | -32.8% | +134.9% | at high | +207.9% |
| 5 y | 5 years | -667.6% | +68.3% | -32.8% | +132.8% | at high | +207.9% |
| alltime | all time | -667.6% | +68.3% | -32.8% | +132.8% | at high | +207.9% |
Terns Pharmaceuticals Cash From Investing History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | $31.75 M(-24.7%) | $129.17 M(+72.0%) |
| June 2024 | - | $42.19 M(+427.6%) | $75.11 M(-229.7%) |
| Mar 2024 | - | $8.00 M(-83.1%) | -$57.92 M(+52.5%) |
| Dec 2023 | -$37.99 M(+70.6%) | $47.23 M(-311.7%) | -$37.99 M(-61.9%) |
| Sept 2023 | - | -$22.31 M(-75.4%) | -$99.77 M(+26.8%) |
| June 2023 | - | -$90.84 M(-425.2%) | -$78.69 M(+1955.2%) |
| Mar 2023 | - | $27.93 M(-292.0%) | -$3.83 M(-82.8%) |
| Dec 2022 | -$22.27 M | -$14.55 M(+1073.1%) | -$22.27 M(+57.4%) |
| Sept 2022 | - | -$1.24 M(-92.2%) | -$14.15 M(+67.1%) |
| June 2022 | - | -$15.97 M(-268.4%) | -$8.46 M(-36.8%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2022 | - | $9.49 M(-247.8%) | -$13.39 M(-88.8%) |
| Dec 2021 | -$119.70 M(-1888.4%) | -$6.42 M(-244.5%) | -$119.70 M(+5.6%) |
| Sept 2021 | - | $4.44 M(-121.3%) | -$113.32 M(-3.8%) |
| June 2021 | - | -$20.90 M(-78.4%) | -$117.77 M(+21.4%) |
| Mar 2021 | - | -$96.82 M(>+9900.0%) | -$96.97 M(-1548.8%) |
| Dec 2020 | $6.69 M(-273.6%) | -$47.00 K(+840.0%) | $6.69 M(-0.7%) |
| Sept 2020 | - | -$5000.00(-95.1%) | $6.74 M(-0.1%) |
| June 2020 | - | -$102.00 K(-101.5%) | $6.75 M(-1.5%) |
| Mar 2020 | - | $6.85 M | $6.85 M |
| Dec 2019 | -$3.86 M(-19.3%) | - | - |
| Dec 2018 | -$4.78 M | - | - |
FAQ
- What is Terns Pharmaceuticals annual cash flow from investing activities?
- What is the all time high annual CFI for Terns Pharmaceuticals?
- What is Terns Pharmaceuticals annual CFI year-on-year change?
- What is Terns Pharmaceuticals quarterly cash flow from investing activities?
- What is the all time high quarterly CFI for Terns Pharmaceuticals?
- What is Terns Pharmaceuticals quarterly CFI year-on-year change?
- What is Terns Pharmaceuticals TTM cash flow from investing activities?
- What is the all time high TTM CFI for Terns Pharmaceuticals?
- What is Terns Pharmaceuticals TTM CFI year-on-year change?
What is Terns Pharmaceuticals annual cash flow from investing activities?
The current annual CFI of TERN is -$37.99 M
What is the all time high annual CFI for Terns Pharmaceuticals?
Terns Pharmaceuticals all-time high annual cash flow from investing activities is $6.69 M
What is Terns Pharmaceuticals annual CFI year-on-year change?
Over the past year, TERN annual cash flow from investing activities has changed by -$15.71 M (-70.56%)
What is Terns Pharmaceuticals quarterly cash flow from investing activities?
The current quarterly CFI of TERN is $31.75 M
What is the all time high quarterly CFI for Terns Pharmaceuticals?
Terns Pharmaceuticals all-time high quarterly cash flow from investing activities is $47.23 M
What is Terns Pharmaceuticals quarterly CFI year-on-year change?
Over the past year, TERN quarterly cash flow from investing activities has changed by +$54.06 M (+242.29%)
What is Terns Pharmaceuticals TTM cash flow from investing activities?
The current TTM CFI of TERN is $129.17 M
What is the all time high TTM CFI for Terns Pharmaceuticals?
Terns Pharmaceuticals all-time high TTM cash flow from investing activities is $129.17 M
What is Terns Pharmaceuticals TTM CFI year-on-year change?
Over the past year, TERN TTM cash flow from investing activities has changed by +$228.94 M (+229.47%)